Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 2466 of 6372
-
Heart monitor could make blood thinners safer for heart attack patients
Disease control OngoingPatients with Acute Coronary Syndrome associated with de novo atrial fibrillation are randomized to benefit from either a conventional therapy associating dual antiplatelet therapy (DAPT) and anticoagulant or DAPT and an implantable monitoring device with a follow-up by telecardi…
Phase 4 • Sponsor: Centre Hospitalier de PAU • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New stent aims to tackle tough heart blockages
Disease control OngoingObservation of the safety and effectiveness of Cre8 stent, Cre8 evo stent in patients with ischemic heart disease with long coronary lesions
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can genetic markers guide better cancer treatment?
Knowledge-focused Recruiting nowThe primary objectives of this prospective non-interventional study (NIS) are to assess and describe outcomes in relation to biomarkers, including whole-genome sequencing (WGS) in patients with non- small cell lung cancer (NSCLC) or breast cancer receiving treatment offered in th…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can we predict Crohn's damage before it happens? a Long-Term study aims to find out
Knowledge-focused OngoingThe investigators propose to create a prospective Crohn Disease cohort, where patients receiving the most up-to-date therapies with a treat-to-target strategy, will be closely followed to characterize the progression of Crohn Disease by measuring the Lémann Index over time. The g…
Sponsor: GLSMED Learning Health S.A. • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Artificial disc shows promise in 5-Year neck pain study
Disease control CompletedThis study is intended to demonstrate the 5-year long-term safety and efficacy of the Simplify® Cervical Artificial Disc ("Simplify Disc") in subjects enrolled in the non-randomized two-level Simplify Disc Investigational Device Exemption (IDE) study. This study was conducted und…
Sponsor: NuVasive • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Massive study reveals best Second-Line diabetes meds for heart and kidney protection
Knowledge-focused OngoingTo perform an observational analysis to emulate a target trial (i.e., a hypothetical pragmatic trial that would have answered the causal question of interest) comparing the effectiveness and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide 1 rec…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Simple bedside exercises could help seniors recover faster after surgery
Symptom relief OngoingLengthy hospitalization and immobility can lead to muscle loss resulting in reduced recovery rates and prolonged hospital stay or readmission. Older adults discharged from hospitals are at an increased risk for functional decline, falls and disability. Daily exercise and physical…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Aerosol chemo spray shows promise for Hard-to-Treat ovarian cancer
Disease control Recruiting nowWomen with a history of tumor response insufficient to allow complete cytoreductive surgery after three cycles of prior neoadjuvant systemic carboplatin-paclitaxel chemotherapy will be prospectively enrolled in this phase I study. After providing written informed consent and conf…
Phase 1 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a simple blood test guide kidney transplant patients to fewer drugs?
Disease control CompletedThe purpose of the study is to identify kidney transplant patients that can be transitioned from multi-drug immunosuppression therapy to Belatacept monotherapy, using cell free DNA and gene expression as markers of immune quiescence. The primary objective will be to determine if …
Phase 4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Brain scans reveal how a brief crisis plan may lower suicide risk
Knowledge-focused CompletedThe current study is a clinical trial, meaning a research study in which human subjects are prospectively assigned to one or more interventions to evaluate the effects of those interventions on health-related behavioral outcomes. Specifically, male and female adults with current …
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Can a single injection numb the chest or belly? a nerve block under the microscope
Knowledge-focused CompletedAlthough erector spinae plane (ESP) block reportedly provides postoperative pain relieve, controversy remains regarding the accuracy and consistency of analgesic success following ESP block. The goal of this study is to determine the extent and duration of clinical neural blockad…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
PNH patients get extended access to iptacopan in safety follow-up
Disease control OngoingThis study is an open-label, single arm, multicenter, roll-over extension study to characterize long-term safety, tolerability and efficacy of iptacopan and to provide access to iptacopan to patients with PNH who have completed Novartis-sponsored Phase 2 or 3 studies with iptacop…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New antibody combo shows promise for Hard-to-Treat myeloma
Disease control Recruiting nowThis Phase Ib, multicenter, open-label study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of cevostamab monotherapy, cevostamab plus pomalidomide and dexamethasone (Pd) or cevostamab plus daratumumab and dexamethasone (Dd) which will be…
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New palliative care program aims to ease suffering for dementia patients and families
Symptom relief CompletedMillions of Americans have late-stage Alzheimer's and related dementias (ADRD), causing suffering due to loss of awareness of self and family, progressive dependency, physical and neuropsychiatric symptoms, and physical, emotional and financial strain for caregivers. Investigator…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Breast cancer prevention study halted: tamoxifen pill vs. gel tested
Prevention Stopped earlyThe investigators plan to prospectively study breast tissue changes after a short course of Tamoxifen (Tam).
Phase 2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Sound waves to soothe anxiety? new trial tests ultrasound on the brain
Symptom relief Recruiting nowThere are few treatment options available for patients once they have failed standard psychopharmacological therapy for generalized anxiety disorder. Existing brain stimulation methods such as rTMS fail to target deep brain structures associated with anxiety disorders; structures…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
200,000 volunteers needed to unlock Cancer's secrets
Knowledge-focused Recruiting nowBackground: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lo…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Could a smartphone app beat a paper diary for migraine management?
Symptom relief CompletedMigraine is a common headache disorder and affects 1 in 5 adults during their lifetime. It is a disorder which leads to significantly impaired quality of life, absence from work, loss of productivity in workplace and reduced vitality in social functioning. One of the important co…
Sponsor: All India Institute of Medical Sciences • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Ovarian cancer drug combo trial halted early
Disease control Stopped earlyThe objective of this study was to assess the efficacy and safety of the combination of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian cancer, with no germline BRCA mutation dete…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a low-fat meal ease stomach side effects of NF1 tumor drug?
Disease control OngoingThis study in adolescent participants with NF1 who have inoperable PN is designed to evaluate the effect of a low fat meal on steady state selumetinib exposure; to assess the effect on GI tolerability when selumetinib is dosed under fed and fasted conditions; and potentially, to …
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC